Status:
UNKNOWN
Effectiveness of Port Site Bupivacaine Injection in Postoperative Pain Reduction After Lap. Chole
Lead Sponsor:
Hamdard University
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18-45 years
Phase:
PHASE3
Brief Summary
To determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.
Detailed Description
The study is being done to determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.
Eligibility Criteria
Inclusion
- Patients of both the gender of age \>18 years and \<45years
- Patients undergoing elective laparoscopic cholecystectomy under general anesthesia.
- Patients with A.S.A grade I and II.
Exclusion
- Patients with known allergic reactions to local anesthetics.
- Patients converted to open procedure.
- Patients developing intra-operative complications.
- Patients undergoing for laparoscopic cholecystectomy for acute cholecystitis.
- Patients with obesity and chronic illness.
- Patients with history of opioids, steroids, NSAIDs and alcohol use.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT05264805
Start Date
March 1 2022
End Date
September 1 2022
Last Update
March 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.